Antifouling Coating
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
Global Antidiabetics Market Research Report 2023
1 Antidiabetics Market Overview
1.1 Product Overview and Scope of Antidiabetics
1.2 Antidiabetics Segment by Type
1.2.1 Global Antidiabetics Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Type 1 Diabetes
1.2.3 Type 2 Diabetes
1.2.4 Other
1.3 Antidiabetics Segment by Application
1.3.1 Global Antidiabetics Sales Comparison by Application: (2022-2028)
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Household
1.3.5 Other
1.4 Global Antidiabetics Market Size Estimates and Forecasts
1.4.1 Global Antidiabetics Revenue 2017-2028
1.4.2 Global Antidiabetics Sales 2017-2028
1.4.3 Antidiabetics Market Size by Region: 2017 Versus 2021 Versus 2028
2 Antidiabetics Market Competition by Manufacturers
2.1 Global Antidiabetics Sales Market Share by Manufacturers (2017-2022)
2.2 Global Antidiabetics Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Antidiabetics Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Antidiabetics Manufacturing Sites, Area Served, Product Type
2.5 Antidiabetics Market Competitive Situation and Trends
2.5.1 Antidiabetics Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Antidiabetics Players Market Share by Revenue
2.5.3 Global Antidiabetics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antidiabetics Retrospective Market Scenario by Region
3.1 Global Antidiabetics Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Antidiabetics Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Antidiabetics Market Facts & Figures by Country
3.3.1 North America Antidiabetics Sales by Country
3.3.2 North America Antidiabetics Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Antidiabetics Market Facts & Figures by Country
3.4.1 Europe Antidiabetics Sales by Country
3.4.2 Europe Antidiabetics Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Antidiabetics Market Facts & Figures by Region
3.5.1 Asia Pacific Antidiabetics Sales by Region
3.5.2 Asia Pacific Antidiabetics Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Antidiabetics Market Facts & Figures by Country
3.6.1 Latin America Antidiabetics Sales by Country
3.6.2 Latin America Antidiabetics Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Antidiabetics Market Facts & Figures by Country
3.7.1 Middle East and Africa Antidiabetics Sales by Country
3.7.2 Middle East and Africa Antidiabetics Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Antidiabetics Historic Market Analysis by Type
4.1 Global Antidiabetics Sales Market Share by Type (2017-2022)
4.2 Global Antidiabetics Revenue Market Share by Type (2017-2022)
4.3 Global Antidiabetics Price by Type (2017-2022)
5 Global Antidiabetics Historic Market Analysis by Application
5.1 Global Antidiabetics Sales Market Share by Application (2017-2022)
5.2 Global Antidiabetics Revenue Market Share by Application (2017-2022)
5.3 Global Antidiabetics Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Sanofi-Aventis
6.1.1 Sanofi-Aventis Corporation Information
6.1.2 Sanofi-Aventis Description and Business Overview
6.1.3 Sanofi-Aventis Antidiabetics Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Sanofi-Aventis Antidiabetics Product Portfolio
6.1.5 Sanofi-Aventis Recent Developments/Updates
6.2 Takeda Pharmaceuticals
6.2.1 Takeda Pharmaceuticals Corporation Information
6.2.2 Takeda Pharmaceuticals Description and Business Overview
6.2.3 Takeda Pharmaceuticals Antidiabetics Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Takeda Pharmaceuticals Antidiabetics Product Portfolio
6.2.5 Takeda Pharmaceuticals Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Antidiabetics Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Eli Lilly Antidiabetics Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Oramed Pharmaceuticals
6.4.1 Oramed Pharmaceuticals Corporation Information
6.4.2 Oramed Pharmaceuticals Description and Business Overview
6.4.3 Oramed Pharmaceuticals Antidiabetics Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Oramed Pharmaceuticals Antidiabetics Product Portfolio
6.4.5 Oramed Pharmaceuticals Recent Developments/Updates
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Corporation Information
6.5.2 Boehringer Ingelheim Description and Business Overview
6.5.3 Boehringer Ingelheim Antidiabetics Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Boehringer Ingelheim Antidiabetics Product Portfolio
6.5.5 Boehringer Ingelheim Recent Developments/Updates
6.6 Merck & Co. Inc.
6.6.1 Merck & Co. Inc. Corporation Information
6.6.2 Merck & Co. Inc. Description and Business Overview
6.6.3 Merck & Co. Inc. Antidiabetics Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Merck & Co. Inc. Antidiabetics Product Portfolio
6.6.5 Merck & Co. Inc. Recent Developments/Updates
6.7 Novo Nordisk
6.6.1 Novo Nordisk Corporation Information
6.6.2 Novo Nordisk Description and Business Overview
6.6.3 Novo Nordisk Antidiabetics Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Novo Nordisk Antidiabetics Product Portfolio
6.7.5 Novo Nordisk Recent Developments/Updates
6.8 Bristol-Myers Squibb
6.8.1 Bristol-Myers Squibb Corporation Information
6.8.2 Bristol-Myers Squibb Description and Business Overview
6.8.3 Bristol-Myers Squibb Antidiabetics Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Bristol-Myers Squibb Antidiabetics Product Portfolio
6.8.5 Bristol-Myers Squibb Recent Developments/Updates
6.9 Halozyme Therapeutics
6.9.1 Halozyme Therapeutics Corporation Information
6.9.2 Halozyme Therapeutics Description and Business Overview
6.9.3 Halozyme Therapeutics Antidiabetics Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Halozyme Therapeutics Antidiabetics Product Portfolio
6.9.5 Halozyme Therapeutics Recent Developments/Updates
6.10 Pfizer
6.10.1 Pfizer Corporation Information
6.10.2 Pfizer Description and Business Overview
6.10.3 Pfizer Antidiabetics Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Pfizer Antidiabetics Product Portfolio
6.10.5 Pfizer Recent Developments/Updates
7 Antidiabetics Manufacturing Cost Analysis
7.1 Antidiabetics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Antidiabetics
7.4 Antidiabetics Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Antidiabetics Distributors List
8.3 Antidiabetics Customers
9 Antidiabetics Market Dynamics
9.1 Antidiabetics Industry Trends
9.2 Antidiabetics Market Drivers
9.3 Antidiabetics Market Challenges
9.4 Antidiabetics Market Restraints
10 Global Market Forecast
10.1 Antidiabetics Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Antidiabetics by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Antidiabetics by Type (2023-2028)
10.2 Antidiabetics Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Antidiabetics by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Antidiabetics by Application (2023-2028)
10.3 Antidiabetics Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Antidiabetics by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Antidiabetics by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Antidiabetics Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Antidiabetics Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Antidiabetics Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Antidiabetics Market Competitive Situation by Manufacturers in 2021
Table 5. Global Antidiabetics Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Antidiabetics Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Antidiabetics Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Antidiabetics Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Antidiabetics Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Antidiabetics Manufacturing Sites and Area Served
Table 11. Manufacturers Antidiabetics Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Antidiabetics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antidiabetics as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Antidiabetics Sales by Region (2017-2022) & (K Units)
Table 16. Global Antidiabetics Sales Market Share by Region (2017-2022)
Table 17. Global Antidiabetics Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Antidiabetics Revenue Market Share by Region (2017-2022)
Table 19. North America Antidiabetics Sales by Country (2017-2022) & (K Units)
Table 20. North America Antidiabetics Sales Market Share by Country (2017-2022)
Table 21. North America Antidiabetics Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Antidiabetics Revenue Market Share by Country (2017-2022)
Table 23. Europe Antidiabetics Sales by Country (2017-2022) & (K Units)
Table 24. Europe Antidiabetics Sales Market Share by Country (2017-2022)
Table 25. Europe Antidiabetics Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Antidiabetics Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Antidiabetics Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Antidiabetics Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Antidiabetics Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Antidiabetics Revenue Market Share by Region (2017-2022)
Table 31. Latin America Antidiabetics Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Antidiabetics Sales Market Share by Country (2017-2022)
Table 33. Latin America Antidiabetics Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Antidiabetics Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Antidiabetics Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Antidiabetics Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Antidiabetics Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Antidiabetics Revenue Market Share by Country (2017-2022)
Table 39. Global Antidiabetics Sales by Type (2017-2022) & (K Units)
Table 40. Global Antidiabetics Sales Market Share by Type (2017-2022)
Table 41. Global Antidiabetics Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Antidiabetics Revenue Share by Type (2017-2022)
Table 43. Global Antidiabetics Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Antidiabetics Sales (K Units) by Application (2017-2022)
Table 45. Global Antidiabetics Sales Market Share by Application (2017-2022)
Table 46. Global Antidiabetics Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Antidiabetics Revenue Share by Application (2017-2022)
Table 48. Global Antidiabetics Price by Application (2017-2022) & (USD/Unit)
Table 49. Sanofi-Aventis Corporation Information
Table 50. Sanofi-Aventis Description and Business Overview
Table 51. Sanofi-Aventis Antidiabetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. Sanofi-Aventis Antidiabetics Product
Table 53. Sanofi-Aventis Recent Developments/Updates
Table 54. Takeda Pharmaceuticals Corporation Information
Table 55. Takeda Pharmaceuticals Description and Business Overview
Table 56. Takeda Pharmaceuticals Antidiabetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. Takeda Pharmaceuticals Antidiabetics Product
Table 58. Takeda Pharmaceuticals Recent Developments/Updates
Table 59. Eli Lilly Corporation Information
Table 60. Eli Lilly Description and Business Overview
Table 61. Eli Lilly Antidiabetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. Eli Lilly Antidiabetics Product
Table 63. Eli Lilly Recent Developments/Updates
Table 64. Oramed Pharmaceuticals Corporation Information
Table 65. Oramed Pharmaceuticals Description and Business Overview
Table 66. Oramed Pharmaceuticals Antidiabetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. Oramed Pharmaceuticals Antidiabetics Product
Table 68. Oramed Pharmaceuticals Recent Developments/Updates
Table 69. Boehringer Ingelheim Corporation Information
Table 70. Boehringer Ingelheim Description and Business Overview
Table 71. Boehringer Ingelheim Antidiabetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Boehringer Ingelheim Antidiabetics Product
Table 73. Boehringer Ingelheim Recent Developments/Updates
Table 74. Merck & Co. Inc. Corporation Information
Table 75. Merck & Co. Inc. Description and Business Overview
Table 76. Merck & Co. Inc. Antidiabetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Merck & Co. Inc. Antidiabetics Product
Table 78. Merck & Co. Inc. Recent Developments/Updates
Table 79. Novo Nordisk Corporation Information
Table 80. Novo Nordisk Description and Business Overview
Table 81. Novo Nordisk Antidiabetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Novo Nordisk Antidiabetics Product
Table 83. Novo Nordisk Recent Developments/Updates
Table 84. Bristol-Myers Squibb Corporation Information
Table 85. Bristol-Myers Squibb Description and Business Overview
Table 86. Bristol-Myers Squibb Antidiabetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Bristol-Myers Squibb Antidiabetics Product
Table 88. Bristol-Myers Squibb Recent Developments/Updates
Table 89. Halozyme Therapeutics Corporation Information
Table 90. Halozyme Therapeutics Description and Business Overview
Table 91. Halozyme Therapeutics Antidiabetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Halozyme Therapeutics Antidiabetics Product
Table 93. Halozyme Therapeutics Recent Developments/Updates
Table 94. Pfizer Corporation Information
Table 95. Pfizer Description and Business Overview
Table 96. Pfizer Antidiabetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Pfizer Antidiabetics Product
Table 98. Pfizer Recent Developments/Updates
Table 99. Production Base and Market Concentration Rate of Raw Material
Table 100. Key Suppliers of Raw Materials
Table 101. Antidiabetics Distributors List
Table 102. Antidiabetics Customers List
Table 103. Antidiabetics Market Trends
Table 104. Antidiabetics Market Drivers
Table 105. Antidiabetics Market Challenges
Table 106. Antidiabetics Market Restraints
Table 107. Global Antidiabetics Sales Forecast by Type (2023-2028) & (K Units)
Table 108. Global Antidiabetics Sales Market Share Forecast by Type (2023-2028)
Table 109. Global Antidiabetics Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 110. Global Antidiabetics Revenue Market Share Forecast by Type (2023-2028)
Table 111. Global Antidiabetics Sales Forecast by Application (2023-2028) & (K Units)
Table 112. Global Antidiabetics Sales Market Share Forecast by Application (2023-2028)
Table 113. Global Antidiabetics Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 114. Global Antidiabetics Revenue Market Share Forecast by Application (2023-2028)
Table 115. Global Antidiabetics Sales Forecast by Region (2023-2028) & (K Units)
Table 116. Global Antidiabetics Sales Market Share Forecast by Region (2023-2028)
Table 117. Global Antidiabetics Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 118. Global Antidiabetics Revenue Market Share Forecast by Region (2023-2028)
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Antidiabetics
Figure 2. Global Antidiabetics Market Share by Type in 2021 & 2028
Figure 3. Type 1 Diabetes Product Picture
Figure 4. Type 2 Diabetes Product Picture
Figure 5. Other Product Picture
Figure 6. Global Antidiabetics Market Share by Application in 2021 & 2028
Figure 7. Hospital Use
Figure 8. Clinic Use
Figure 9. Household
Figure 10. Other
Figure 11. Global Antidiabetics Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Antidiabetics Market Size (2017-2028) & (US$ Million)
Figure 13. Global Antidiabetics Sales (2017-2028) & (K Units)
Figure 14. Antidiabetics Sales Share by Manufacturers in 2021
Figure 15. Global Antidiabetics Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest Antidiabetics Players: Market Share by Revenue in 2021
Figure 17. Antidiabetics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Antidiabetics Sales Market Share by Region (2017-2022)
Figure 19. Global Antidiabetics Sales Market Share by Region in 2021
Figure 20. Global Antidiabetics Revenue Market Share by Region (2017-2022)
Figure 21. Global Antidiabetics Revenue Market Share by Region in 2021
Figure 22. U.S. Antidiabetics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Canada Antidiabetics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Germany Antidiabetics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. France Antidiabetics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. U.K. Antidiabetics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Italy Antidiabetics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Russia Antidiabetics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. China Antidiabetics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Japan Antidiabetics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. South Korea Antidiabetics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. India Antidiabetics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Australia Antidiabetics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Taiwan Antidiabetics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Indonesia Antidiabetics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Thailand Antidiabetics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Malaysia Antidiabetics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Philippines Antidiabetics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Vietnam Antidiabetics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Mexico Antidiabetics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Brazil Antidiabetics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Argentina Antidiabetics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Turkey Antidiabetics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Saudi Arabia Antidiabetics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. U.A.E Antidiabetics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Sales Market Share of Antidiabetics by Type (2017-2022)
Figure 47. Manufacturing Cost Structure of Antidiabetics
Figure 48. Manufacturing Process Analysis of Antidiabetics
Figure 49. Antidiabetics Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi-Aventis Takeda Pharmaceuticals Eli Lilly Oramed Pharmaceuticals Boehringer Ingelheim Merck & Co. Inc. Novo Nordisk Bristol-Myers Squibb Halozyme Therapeutics Pfizer